Dror Sever

Dror Sever

Auto-generated profile, based on publicly available information

Dror Sever

Novo Nordisk Foundation Center for Stem Cell Biology (DanStem), University of Copenhagen, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
KKKeiichi Katsumoto
Keiichi Katsumoto
SYSiham Yennek
Siham Yennek
CCChunguang Chen
Chunguang Chen
LSLuis Fernando Delgadillo Silva
Luis Fernando Delgadillo Silva
STSofia Traikov
Sofia Traikov
AGAnne Grapin-Botton
Anne Grapin-Botton
Diabetes is a multifactorial disorder characterized by loss or dysfunction of pancreatic β-cells. β-cells are heterogeneous, exhibiting different glucose sensing, insulin secretion and gene expression. They communicate with other endocrine cell types via paracrine signals and between β-cells via gap junctions. Here, we identify the importance of signaling between β-cells via the extracellular signal WNT4. We show heterogeneity in Wnt4 expression, most strikingly in the postnatal maturation period, Wnt4-positive cells, being more mature while Wnt4-negative cells are more proliferative. Knock-out in adult β-cells shows that WNT4 controls the activation of calcium signaling in response to a glucose challenge, as well as metabolic pathways converging to lower ATP/ADP ratios, thereby reducing insulin secretion. These results reveal that paracrine signaling between β-cells is important in addition to gap junctions in controling insulin secretion. Together with previous reports of WNT4 up-regulation in obesity our observations suggest an adaptive insulin response coordinating β-cells.

1 September 2015 in Developmental Biology
Verified
Journal Article
Closed access
David MartinDavid Martin
David Martin
HKHae Kim
Hae Kim
DSDror Sever
Dror Sever
CMChai-An Mao
Chai-An Mao
JHJacques-Antoine Haefliger
Jacques-Antoine Haefliger
AGAnne Grapin-Botton
Anne Grapin-Botton

30 November 2010 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
DSDror Sever
Dror Sever
RERoy Eldor
Roy Eldor
GSGadi Sadoun
Gadi Sadoun
LALivnat Amior
Livnat Amior
DDDaniele Dubois
Daniele Dubois
DMDanielle Melloul
Danielle Melloul
Insulin‐producing pancreatic β cells are functionally impaired or destroyed in diabetes mellitus. The onset of type 1 diabetes (T1D) represents the culmination of a prolonged prediabetic phase of immune‐mediated β‐cell destruction. To assess the in vivo metabolic status of these cells, we used the ATP‐sensitive firefly luciferase bioluminescence imaging approach, as a noninvasive probe to monitor pathological alterations in β‐cell function in the nonobese‐diabetic (NOD) mouse model of T1D. Hence, we generated the Tolβ‐NOD transgenic mice in which doxycycline‐induc‐ible luciferase gene is selectively expressed in β cells. A sharp reduction in bioluminescence emitted in vivo from β cells at the early stages, preceded by several weeks of a limited reduction in β‐cell mass. Since this decline could be due to the ongoing inflammatory process occurring in vivo , we exposed control islets to inflammatory cytokines and observed a dramatic decrease in luciferase luminescence, which appears to be due in part to a decrease in protein levels and a drop in intracellular ATP levels. This is the first evidence that selective expression of the luciferase gene represents a sensitive method for noninvasive in vivo monitoring of early β‐cell dysfunction, subtle metabolic changes, such as endogenous ATP levels, indicative of a pathological condition in a tissue at the cellular level.—Sever, D., Eldor, R., Sadoun, G., Amior, L., Dubois, D., Boitard, C., Aflalo, C., Melloul, D. Evaluation of impaired β‐cell function in nonobese‐diabetic (NOD) mouse model using bioluminescence imaging. FASEB J. 25, 676–684 (2011). www.fasebj.org